#NewYorkBronxZooTiger; #coronavirus; # WildlifeConservationSociety; #USDA; #BronxZoo
New York, Apr 6 (Canadian-Media): Nadia, a 4-year-old female Malayan tiger at the Bronx Zoo in New York, has become the first of her kind, to test positive for the coronavirus after developing a dry cough, media reports said.
Nadia. Image credit: Twitter
Nadia is expected to recover, the Wildlife Conservation Society's Bronx Zoo said in a news release.
Samples from Nadia were taken and tested after the tiger, and five other tigers and lions at the zoo, exhibited symptoms of respiratory illness, according to the United States Department of Agriculture (USDA). No other animals at the zoo are showing symptoms.
"Though they have experienced some decrease in appetite, the cats at the Bronx Zoo are otherwise doing well under veterinary care and are bright, alert, and interactive with their keepers," the zoo said."It is not known how this disease will develop in big cats since different species can react differently to novel infections, but we will continue to monitor them closely and anticipate full recoveries."
The Covid-19 testing on Nadia was performed in a veterinary school laboratory and is not the same test used for people, Dr. Paul Calle, the zoo's chief veterinarian, posted on Facebook.
The animals were infected by an asymptomatically infected zoo employee caring for them, according to the zoo. The Bronx Zoo has been closed to the public since March 16.
USDA advises anyone sick with the coronavirus to minimize contact with animals, including pets, until more information is known about the virus, the USDA said.
#Camels, #Australia; #DroughtHitAreas; #CullingOfCamels
Sydney (Australia), Jan 14 (Canadian-Media): Culling of more than 5,000 feral camels over the last five days has been completed by Australia as these camels were a threat to the survival of indigenous communities in drought-hit areas of southern Australia, media reports said.
Camels in Australia. Image credit: Phys.org
The aboriginal leaders said that the large herds of the non-native camels driven towards rural habitats not only threatened scarce food and water in the arid region, but was also a threat to the infrastructure and posed a hazard for the drivers.
The culling was carried out by helicopter-borne marksmen in Anangu Pitjantjatjara Yankunytjatjara (APY) Lands -- home to 2,300 indigenous people -- and completed on Sunday, said APY general manager Richard King.
"We appreciate the concerns of animal rights activists, but there is significant misinformation about the realities of life for non-native feral animals, in what is among the aridest and remote places on Earth," King said in a statement on Tuesday.
He said the camels were responsible for introducing pests and the valuable water supplies for communities needed to be protected from them.
Prolonged dry periods is well tolerated by native wildlife, is distressful for feral camels, King said.
In 1840s the British had imported around 20,000 Indian camels to Australia to explore the interiors of Australia.
#AfricanSwineFever; #PigsDeath; #WorldOrganizationforAnimalHealth
Ottawa, Nov 1 (Canadian-Media): Rapidly spreading African swine fever may kill around a quarter of the world's pigs, said the president of the World Organization for Animal Health said Thursday.
Pig at risk of African Swine Fever/Twitter
A world crisis had already arisen due to spread of this fatal disease to countries including China, which has half the world's pigs
The disease's spread in the past year to countries including China, , had inflamed a global crisis, Schipp told reporters at a briefing in Sydney.
"I don't think the species will be lost, but it's the biggest threat to the commercial raising of pigs we've ever seen," said Dr. Mark Schipp, Australia's chief veterinary officer "And it's the biggest threat to any commercial livestock of our generation."
African swine fever, fatal to hogs but no threat to humans, has wiped out pig herds in many Asian countries. Chinese authorities have destroyed about 1.2 million pigs in an effort to contain the disease there since August 2018.
Schipp said quality control was difficult for products such as skins for sausages, salamis and similar foods.
Florida (U.S.A.) October 28, 2019: An announcement was made today by Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global platform biotechnology company, that it has entered into a fully funded collaboration with one of the leading animal health companies, media reports said.
Under the terms of the agreement, Dyadic will apply its proprietary and patented C1 gene expression platform to express three different types of proteins to be evaluated by our collaborator for its potential use in their research and commercial projects.
Dyadic International is developing a potentially significant biopharmaceutical gene expression platform based on the fungus Myceliophthora thermophila, named C1.
Dyadic is using the C1 technology and other technologies to conduct research, development and commercial activities for the development and manufacturing of human and animal vaccines and drugs (such as virus like particles (VLPs) and antigens), monoclonal antibodies, Fab antibody fragments, Fc-Fusion proteins, biosimilars and/or biobetters, and other therapeutic proteins.
"Today's announcement further evidences the broad applications of our C1 technology platform for both human and animal health needs. This collaboration in the animal health markets reinforces our momentum in another high growth sector, companion and farm animal health. The regulatory pathway in animal health, compared to human trials for biologics approvals, is much shorter with the cost of goods being a much more critical issue. We believe that our C1 technology platform uniquely addresses these issues and provides us with another potential catalyst for growth," said CEO Mark Emalfarb.
"We are excited to announce an additional animal health-related research agreement...to help speed the development, lower the cost and improve the performance of biologic vaccines and drugs for both farm and companion animals...increasing interest from both our previously announced collaborators as well as other bio-pharmaceutical companies involved in the animal health sector," commented Matthew Jones, Dyadic's Chief Commercial Officer.